We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Air Filter with `Catch and Kill` Technology Eliminates Airborne Viruses, Including COVID-19 Variants

By HospiMedica International staff writers
Posted on 07 Jan 2022

The only air filter in the world proven to "catch and kill" airborne COVID-19, Anthrax spores, bacteria, allergens, and other asthma triggers was launched at the 2022 Consumer Electronics Show (CES). More...

Integrated Viral Protection, LLC (Houston, TX, USA) demonstrated its scientifically proven technology with the release of its new Personal Air Filtration Unit to provide additional protection with the vaccine.

IVP allows breathing with confidence by changing the way air is cleaned. This patented technology, based on science, kills airborne viruses in a single pass, including sub-micron variants causing COVID-19, anthrax spores, allergens, and other harmful respiratory triggers. IVP units use a heated foam stainless steel mesh embedded inside a HEPA filter to kill airborne pathogens instantly and removing these pathogens from the air.

The FDA EUA approved Personal Air Filtration Unit was designed to reduce person-to-person virus transmission and is ideal for schools, office spaces, mass transit, and other small indoor spaces IVP's products have been deployed in businesses, health care facilities, schools, and homes around the globe, providing an extra layer of protection to keep indoor spaces safer.

"The time for action is now to combat this virus and its many mutations," said Monzer Hourani, inventor of IVP's indoor air protection system.

Related Links:
Integrated Viral Protection, LLC 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Immobilization System
Cranial 4Pi Immobilization
New
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.